HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Transient infantile hypertriglyceridemia, fatty liver, and hepatic fibrosis caused by mutated GPD1, encoding glycerol-3-phosphate dehydrogenase 1.

Abstract
The molecular basis for primary hereditary hypertriglyceridemia has been identified in fewer than 5% of cases. Investigation of monogenic dyslipidemias has the potential to expose key metabolic pathways. We describe a hitherto unreported disease in ten individuals manifesting as moderate to severe transient childhood hypertriglyceridemia and fatty liver followed by hepatic fibrosis and the identification of the mutated gene responsible for this condition. We performed SNP array-based homozygosity mapping and found a single large continuous segment of homozygosity on chromosomal region 12q13.12. The candidate region contained 35 genes that are listed in Online Mendelian Inheritance in Man (OMIM) and 27 other genes. We performed candidate gene sequencing and screened both clinically affected individuals (children and adults with hypertriglyceridemia) and also a healthy cohort for mutations in GPD1, which encodes glycerol-3-phosphate dehydrogenase 1. Mutation analysis revealed a homozygous splicing mutation, c.361-1G>C, which resulted in an aberrantly spliced mRNA in the ten affected individuals. This mutation is predicted to result in a truncated protein lacking essential conserved residues, including a functional site responsible for initial substrate recognition. Functional consequences of the mutation were evaluated by measuring intracellular concentrations of cholesterol and triglyceride as well as triglyceride secretion in HepG2 (hepatocellular carcinoma) human cells lines overexpressing normal and mutant GPD1 cDNA. Overexpression of mutant GPD1 in HepG2 cells, in comparison to overexpression of wild-type GPD1, resulted in increased secretion of triglycerides (p = 0.01). This finding supports the pathogenicity of the identified mutation.
AuthorsLina Basel-Vanagaite, Noam Zevit, Adi Har Zahav, Liang Guo, Saj Parathath, Metsada Pasmanik-Chor, Adam D McIntyre, Jian Wang, Adi Albin-Kaplanski, Corina Hartman, Daphna Marom, Avraham Zeharia, Abir Badir, Oded Shoerman, Amos J Simon, Gideon Rechavi, Mordechai Shohat, Robert A Hegele, Edward A Fisher, Raanan Shamir
JournalAmerican journal of human genetics (Am J Hum Genet) Vol. 90 Issue 1 Pg. 49-60 (Jan 13 2012) ISSN: 1537-6605 [Electronic] United States
PMID22226083 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Triglycerides
  • Cholesterol
  • Glycerol-3-Phosphate Dehydrogenase (NAD+)
Topics
  • Adolescent
  • Alternative Splicing (genetics)
  • Base Sequence
  • Child
  • Child, Preschool
  • Cholesterol (analysis)
  • Chromosomes, Human, Pair 12 (genetics)
  • Cohort Studies
  • DNA Mutational Analysis
  • Fatty Liver (genetics)
  • Female
  • Glycerol-3-Phosphate Dehydrogenase (NAD+) (genetics)
  • Hep G2 Cells
  • Humans
  • Hypertriglyceridemia (genetics)
  • Infant
  • Liver Cirrhosis (genetics)
  • Male
  • Molecular Sequence Data
  • Mutation
  • Severity of Illness Index
  • Triglycerides (analysis, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: